Variants for Coronary Disease

Premium

The Wellcome Trust Centre for Human Genetics' Martin Farrall and his colleagues at the Procardis consortium linked two variants in the lipoapoprotein(a) gene to an increased risk of coronary disease and an increased level of Lp(a) in the blood. Their large-scale study was recently published in the New England Journal of Medicine. GT's Ciara Curtin caught up with Farrall to discuss his work.

Genome Technology: Why did you focus on variants associated with Lp(a) lipoprotein levels?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.